Faculty profile

Adel Schwertani

ResearcherMedicine/CardiologyMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Adel Schwertani

Researcher

Medicine/Cardiology

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
7 publications in the last five years, latest in 2025.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 3 research grants (2 CIHR, 1 NSERC), most recently in 2017.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Aortic Valve Stenosis Human Interstitial Cells Lipoproteins Mice Therapy

Latest papers

Cardiac biomarkers predict low right ventricle performance in neonatal encephalopathy.
Journal of perinatology : official journal of the California Perinatal Association · 2025
Evaluating the Reparative Potential of Secretome from Patient-Derived Induced Pluripotent Stem Cells during Ischemia-Reperfusion Injury in Human Cardiomyocytes.
International journal of molecular sciences · 2024
Significance of the Wnt signaling pathway in coronary artery atherosclerosis.
Frontiers in cardiovascular medicine · 2024 · senior author

All 33 publications

Latest funding

Desmocollin 1 (DSC1) and atherosclerosis
CIHR · 2019 · Co-investigator
$765,000
Mechanism of human valve interstitial cell calcification
NSERC · 2017 · Principal investigator
$150,000
role of lipoprotein (a) in the pathogenesis of aortic valve calcification
CIHR · 2016 · Nominated PI
$100,000

All 6 grants and awards

33 publications.

Cardiac biomarkers predict low right ventricle performance in neonatal encephalopathy.

Moore SS, Lapointe A, Rampakakis E, Simoneau J, Elias P, Poccia A, Balushi AA, Schwertani A, Wintermark P, Altit G

Journal of perinatology : official journal of the California Perinatal Association2025

DOI: 10.1038/s41372-025-02262-9 PMID: 40089578

Evaluating the Reparative Potential of Secretome from Patient-Derived Induced Pluripotent Stem Cells during Ischemia-Reperfusion Injury in Human Cardiomyocytes.

Rody E, Zwaig J, Derish I, Khan K, Kachurina N, Gendron N, Giannetti N, Schwertani A, Cecere R

International journal of molecular sciences2024

DOI: 10.3390/ijms251910279 PMID: 39408608

Significance of the Wnt signaling pathway in coronary artery atherosclerosis.

Khan K, Yu B, Tardif JC, Rhéaume E, Al-Kindi H, Filimon S, Pop C, Genest J, Cecere R, Schwertani A

Frontiers in cardiovascular medicine2024Senior author

DOI: 10.3389/fcvm.2024.1360380 PMID: 38586172

Chymase Inhibition Resolves and Prevents Deep Vein Thrombosis Without Increasing Bleeding Time in the Mouse Model.

Lapointe C, Vincent L, Giguère H, Auger-Messier M, Schwertani A, Jin D, Takai S, Pejler G, Sirois MG, Tinel H, Heitmeier S, D'Orléans-Juste P

Journal of the American Heart Association2023

DOI: 10.1161/jaha.122.028056 PMID: 36752268

Bioactive Scaffolds in Stem Cell-Based Therapies for Myocardial Infarction: a Systematic Review and Meta-Analysis of Preclinical Trials.

Khan K, Gasbarrino K, Mahmoud I, Dufresne L, Daskalopoulou SS, Schwertani A, Cecere R

Stem cell reviews and reports2022

DOI: 10.1007/s12015-021-10186-y PMID: 34463903

Extracellular Vesicles as a Cell-free Therapy for Cardiac Repair: a Systematic Review and Meta-analysis of Randomized Controlled Preclinical Trials in Animal Myocardial Infarction Models.

Khan K, Caron C, Mahmoud I, Derish I, Schwertani A, Cecere R

Stem cell reviews and reports2022

DOI: 10.1007/s12015-021-10289-6 PMID: 35107768

Amniotic stromal stem cell-loaded hydrogel repairs cardiac tissue in infarcted rat hearts via paracrine mediators.

Khan K, Makhoul G, Yu B, Jalani G, Derish I, Rutman AK, Cerruti M, Schwertani A, Cecere R

Journal of tissue engineering and regenerative medicine2022

DOI: 10.1002/term.3262 PMID: 34726328

COVID-19 and the cardiovascular system: insights into effects and treatments.

Chammas J, Delaney D, Chabaytah N, Abdulkarim S, Schwertani A

Canadian journal of physiology and pharmacology2021Senior author

DOI: 10.1139/cjpp-2021-0093 PMID: 34546123

Urotensin II, urotensin-related peptide, and their receptor in aortic valve stenosis.

Khan K, Albanese I, Yu B, Shalal Y, Al-Kindi H, Alaws H, Tardif JC, Gourgas O, Cerutti M, Schwertani A

The Journal of thoracic and cardiovascular surgery2021Senior author

DOI: 10.1016/j.jtcvs.2019.09.029 PMID: 31679703

The Role of Wnt/β-Catenin Pathway Mediators in Aortic Valve Stenosis.

Khan K, Yu B, Kiwan C, Shalal Y, Filimon S, Cipro M, Shum-Tim D, Cecere R, Schwertani A

Frontiers in cell and developmental biology2020Senior author

DOI: 10.3389/fcell.2020.00862 PMID: 33015048

Something wrong or missing on this profile? Suggest a correction

Adel Schwertani

Research

Latest papers

Latest funding

Cardiac biomarkers predict low right ventricle performance in neonatal encephalopathy.

Evaluating the Reparative Potential of Secretome from Patient-Derived Induced Pluripotent Stem Cells during Ischemia-Reperfusion Injury in Human Cardiomyocytes.

Significance of the Wnt signaling pathway in coronary artery atherosclerosis.

Chymase Inhibition Resolves and Prevents Deep Vein Thrombosis Without Increasing Bleeding Time in the Mouse Model.

Bioactive Scaffolds in Stem Cell-Based Therapies for Myocardial Infarction: a Systematic Review and Meta-Analysis of Preclinical Trials.

Extracellular Vesicles as a Cell-free Therapy for Cardiac Repair: a Systematic Review and Meta-analysis of Randomized Controlled Preclinical Trials in Animal Myocardial Infarction Models.

Amniotic stromal stem cell-loaded hydrogel repairs cardiac tissue in infarcted rat hearts via paracrine mediators.

COVID-19 and the cardiovascular system: insights into effects and treatments.

Urotensin II, urotensin-related peptide, and their receptor in aortic valve stenosis.

The Role of Wnt/&#x3b2;-Catenin Pathway Mediators in Aortic Valve Stenosis.

Desmocollin 1 (DSC1) and atherosclerosis

Mechanism of human valve interstitial cell calcification

role of lipoprotein (a) in the pathogenesis of aortic valve calcification

Novel mechanism of atherosclerotic plaque progression mediated by mouse Mast Cell Protease-4

Significance of the urotensin II system in the cardiovascular abnormalities of the metabolic syndrome

Characterization of the chymase-dependent production of Endothelin-1 in the cardiovascular system

Frequent collaborators

Jacques Genest

Jean-Claude Tardif

Jean-Claude Tardif

Robert Day

George Thanassoulis

Louise Pilote

Gerardo Ferbeyre

David Chatenet

Danielle Jacques

Gabriel Altit

Anie Lapointe

Nadia Giannetti

Julie Fradette

Gabriel Altit

Satya Prakash

Ghassan Bkaily

Louise Pilote

Gerardo Ferbeyre

Mannix Auger-Messier

Pia Wintermark

Sheela Ramanathan

Marek Rola-Pleszczynski

Jana Stankova

Subburaj Ilangumaran

Jerry Pelletier

Martin Lepage

Alfredo Menendez

Marie-France Langlois

Satya Prakash

The Role of Wnt/β-Catenin Pathway Mediators in Aortic Valve Stenosis.